Boston Scientific Gross Profit vs. Profit Margin
| 0HOY Stock | 89.17 0.04 0.04% |
Gross Profit | First Reported 2012-12-31 | Previous Quarter 2.8 B | Current Value 2.6 B | Quarterly Volatility 401.6 M |
For Boston Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Boston Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Boston Scientific Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Boston Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Boston Scientific Corp over time as well as its relative position and ranking within its peers.
Boston |
Boston Scientific Corp Profit Margin vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Boston Scientific's current stock value. Our valuation model uses many indicators to compare Boston Scientific value to that of its competitors to determine the firm's financial worth. Boston Scientific Corp is number one stock in gross profit category among its peers. It is rated fifth in profit margin category among its peers . The ratio of Gross Profit to Profit Margin for Boston Scientific Corp is about 77,078,152,753 . At this time, Boston Scientific's Gross Profit is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boston Scientific's earnings, one of the primary drivers of an investment's value.Boston Profit Margin vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Boston Scientific |
| = | 8.68 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Boston Scientific |
| = | 0.11 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Boston Profit Margin Comparison
Boston Scientific is currently under evaluation in profit margin category among its peers.
Boston Scientific Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Boston Scientific, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Boston Scientific will eventually generate negative long term returns. The profitability progress is the general direction of Boston Scientific's change in net profit over the period of time. It can combine multiple indicators of Boston Scientific, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 50 M | 47.5 M | |
| Operating Income | 2.3 B | 1.5 B | |
| Income Before Tax | 2 B | 2.1 B | |
| Total Other Income Expense Net | -359 M | -376.9 M | |
| Net Income | 1.6 B | 1.7 B | |
| Income Tax Expense | 393 M | 412.6 M | |
| Interest Income | 306.9 M | 253.1 M | |
| Net Income Applicable To Common Shares | 577.8 M | 1.1 B | |
| Change To Netincome | 801.5 M | 841.6 M |
Boston Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Boston Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Boston Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Boston Scientific's important profitability drivers and their relationship over time.
Use Boston Scientific in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.Boston Scientific Pair Trading
Boston Scientific Corp Pair Trading Analysis
The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.
The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Boston Scientific position
In addition to having Boston Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.